About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial

April 17, 2015

click here to read more

Post navigation

Phosphagenics Appoints Three New Directors

Appendix 3X Notices – Three New Directors

Related Posts

Placement to Advance Phase III Clinical Trial

August 28, 2023August 28, 2023

Avecho’s Phase III Clinical Trial for Insomnia Commences

March 26, 2024March 26, 2024

Oxymorphone Patch Program Update

May 14, 2015

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.